and/or
300 News Items found
Researchers Russell Kunes, Thomas Walle, and Dana Pe'er
MSK Researchers Develop New Open-Source Method To Improve Decoding of Single-Cell Data
MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023
New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
Dr. Teddy Yewdell presenting at the MSK Postdoc Slam and in front of the sign of his new employer, Genentech.
Training the Next Generation of Scientists: Meet 3 Remarkable MSK Alumni
At MSK, our goal is not just to train the scientists of tomorrow, but the scientific leaders.
sperm maturation in the fly testis
Rumble in the Genome: Unlocking the Secrets of the Tiny RNAs That Keep Self-Serving, Harmful Genes in Check
The common wisdom is that genes are preserved from generation to generation because they help the organism survive and reproduce. But MSK's Dr. Eric Lai’s team is showing — in fruit flies — that certain genes can threaten a species’ very survival by pursuing their narrow self-interests in passing along their own genetic material.
MSK researcher in a lab
MSK Research Highlights, August 24, 2023
New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.
Chi Nguyen
2023 GSK Chairman’s Prize Recognizes Chi Nguyen, Research on Gut Health
The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023
New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
New MACHETE Technique Slices Into Cancer Genome To Study Copy Number Alterations
Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells
A protein in the body that protects against viruses can also cause cancer-related mutations.